Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
276.5 USD | +3.07% | -1.08% | -14.43% |
05-08 | UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating | MT |
05-08 | RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.43% | 7.71B | |
-4.93% | 183B | |
+0.08% | 108B | |
-3.54% | 67.51B | |
+3.19% | 50.67B | |
+9.12% | 44.7B | |
+2.41% | 40.95B | |
+6.09% | 26.8B | |
+4.01% | 26.71B | |
+12.66% | 24.62B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- RBC Trims Price Target on Bio-Rad Laboratories to $480 From $484, Keeps Outperform Rating